Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, CA

Clinical Trial Details


Research Study Summary

Alzheimers? Be a Part of Research.


This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline of Alzheimer's disease as compared with placebo (a substance that looks like the study drug, but has no medicine).

Qualified Participants Must: Be diagnosed with a mild to moderate form of Alzheimer's disease; Have a reliable caregiver who is in frequent contact with you; Have good veins

Qualified Participants Will Receive: $50 per completed study visit.

To Learn more

CW ID: 157013
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Both Male and Female
Overall Status
Facility Type
$50 and up


Apex Research Institute
999 N. Tustin Ave., #120
Santa Ana, CA 92705
Phone: 714-542-3008

View Map

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.